Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol)

Martin Burton; Janet E. Clarkson; Beatriz Goulao; Anne-Marie Glenny; Andrew J. McBain; Anne G.M. Schilder; Katie E. Webster; Helen V Worthington

doi:10.1002/14651858.CD013627

Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol)

Martin Burton^* (Corresponding Author), Janet E. Clarkson, Beatriz Goulao, Anne-Marie Glenny, Andrew J. McBain, Anne G.M. Schilder, Katie E. Webster, Helen V Worthington

^*Corresponding author for this work

Health Services Research Unit (HSRU)

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

2 Downloads (Pure)

Abstract

Objectives
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the benefits and harms of antimicrobial mouthwashes and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection in order to protect the healthcare workers (HCWs) caring for them.

To assess the benefits and harms of antimicrobial mouthwashes and nasal spray in improving outcomes for patients with suspected or confirmed COVID‐19 infection.

Original language	English
Article number	CD013627
Number of pages	11
Journal	Cochrane Database of Systematic Reviews
Volume	2020
Issue number	5
DOIs	https://doi.org/10.1002/14651858.CD013627
Publication status	Published - 20 May 2020

Bibliographical note

Sources of support
Internal sources
No sources of support supplied

External sources
National Institute for Health Research, UK
Infrastructure funding for Cochrane ENT and Cochrane Oral Health

Acknowledgements
We would like to thank the peer reviewers, Professor Jeremy Bagg, Dr Karolin Hijazi, Professor Carl Philpott and Professor Claire Hopkins, for their insightful comments which helped us to improve these protocols. Thanks also to Professor Peter Tugwell, Senior Editor Cochrane MOSS Network, for acting as sign‐off editor for these projects.

We are also grateful to Doug Salzwedel from the Cochrane Hypertension Group for providing search peer review comments for the draft search strategy.

This project was supported by the National Institute for Health Research, via Cochrane Infrastructure, Cochrane Programme Grant or Cochrane Incentive funding to Cochrane ENT and Cochrane Oral Health. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

Access to Document

10.1002/14651858.CD013627Licence: Unspecified

Burton_et_al_CDSR_AntimicrobialMouthwashes_VoR
This Protocol of a Cochrane Review was published in the Cochrane Database of Systematic Reviews 2020, Issue 5. Cochrane Protocols and Reviews are regularly updated as new evidence emerges and in response to feedback, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Protocol.
Final published version, 136 KBLicence: Unspecified

Fingerprint

Dive into the research topics of 'Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol)'. Together they form a unique fingerprint.

Cite this

Burton, M., Clarkson, J. E., Goulao, B., Glenny, A.-M., McBain, A. J., Schilder, A. G. M., Webster, K. E., & Worthington, H. V. (2020). Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol). Cochrane Database of Systematic Reviews, 2020(5), Article CD013627. https://doi.org/10.1002/14651858.CD013627

Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol). / Burton, Martin (Corresponding Author); Clarkson, Janet E.; Goulao, Beatriz et al.
In: Cochrane Database of Systematic Reviews, Vol. 2020, No. 5, CD013627, 20.05.2020.

Research output: Contribution to journal › Article › peer-review

Burton, M, Clarkson, JE, Goulao, B, Glenny, A-M, McBain, AJ, Schilder, AGM, Webster, KE & Worthington, HV 2020, 'Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol)', Cochrane Database of Systematic Reviews, vol. 2020, no. 5, CD013627. https://doi.org/10.1002/14651858.CD013627

Burton M, Clarkson JE, Goulao B, Glenny AM, McBain AJ, Schilder AGM et al. Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol). Cochrane Database of Systematic Reviews. 2020 May 20;2020(5):CD013627. doi: 10.1002/14651858.CD013627

@article{59d26d1139ca4e79a34b133d88cc9b06,

title = "Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol)",

abstract = "ObjectivesThis is a protocol for a Cochrane Review (intervention). The objectives are as follows:To assess the benefits and harms of antimicrobial mouthwashes and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection in order to protect the healthcare workers (HCWs) caring for them.To assess the benefits and harms of antimicrobial mouthwashes and nasal spray in improving outcomes for patients with suspected or confirmed COVID‐19 infection.",

author = "Martin Burton and Clarkson, {Janet E.} and Beatriz Goulao and Anne-Marie Glenny and McBain, {Andrew J.} and Schilder, {Anne G.M.} and Webster, {Katie E.} and Worthington, {Helen V}",

note = "Sources of support Internal sources No sources of support supplied External sources National Institute for Health Research, UK Infrastructure funding for Cochrane ENT and Cochrane Oral Health Acknowledgements We would like to thank the peer reviewers, Professor Jeremy Bagg, Dr Karolin Hijazi, Professor Carl Philpott and Professor Claire Hopkins, for their insightful comments which helped us to improve these protocols. Thanks also to Professor Peter Tugwell, Senior Editor Cochrane MOSS Network, for acting as sign‐off editor for these projects. We are also grateful to Doug Salzwedel from the Cochrane Hypertension Group for providing search peer review comments for the draft search strategy. This project was supported by the National Institute for Health Research, via Cochrane Infrastructure, Cochrane Programme Grant or Cochrane Incentive funding to Cochrane ENT and Cochrane Oral Health. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.",

year = "2020",

month = may,

day = "20",

doi = "10.1002/14651858.CD013627",

language = "English",

volume = "2020",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Wiley",

number = "5",

}

TY - JOUR

T1 - Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol)

AU - Burton, Martin

AU - Clarkson, Janet E.

AU - Goulao, Beatriz

AU - Glenny, Anne-Marie

AU - McBain, Andrew J.

AU - Schilder, Anne G.M.

AU - Webster, Katie E.

AU - Worthington, Helen V

N1 - Sources of support Internal sources No sources of support supplied External sources National Institute for Health Research, UK Infrastructure funding for Cochrane ENT and Cochrane Oral Health Acknowledgements We would like to thank the peer reviewers, Professor Jeremy Bagg, Dr Karolin Hijazi, Professor Carl Philpott and Professor Claire Hopkins, for their insightful comments which helped us to improve these protocols. Thanks also to Professor Peter Tugwell, Senior Editor Cochrane MOSS Network, for acting as sign‐off editor for these projects. We are also grateful to Doug Salzwedel from the Cochrane Hypertension Group for providing search peer review comments for the draft search strategy. This project was supported by the National Institute for Health Research, via Cochrane Infrastructure, Cochrane Programme Grant or Cochrane Incentive funding to Cochrane ENT and Cochrane Oral Health. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

PY - 2020/5/20

Y1 - 2020/5/20

N2 - ObjectivesThis is a protocol for a Cochrane Review (intervention). The objectives are as follows:To assess the benefits and harms of antimicrobial mouthwashes and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection in order to protect the healthcare workers (HCWs) caring for them.To assess the benefits and harms of antimicrobial mouthwashes and nasal spray in improving outcomes for patients with suspected or confirmed COVID‐19 infection.

AB - ObjectivesThis is a protocol for a Cochrane Review (intervention). The objectives are as follows:To assess the benefits and harms of antimicrobial mouthwashes and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection in order to protect the healthcare workers (HCWs) caring for them.To assess the benefits and harms of antimicrobial mouthwashes and nasal spray in improving outcomes for patients with suspected or confirmed COVID‐19 infection.

UR - http://www.scopus.com/inward/record.url?scp=85085077972&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD013627

DO - 10.1002/14651858.CD013627

M3 - Article

SN - 1469-493X

VL - 2020

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 5

M1 - CD013627

ER -

Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol)

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this